[go: up one dir, main page]

CN1170578A - Dilong Capsules - Google Patents

Dilong Capsules Download PDF

Info

Publication number
CN1170578A
CN1170578A CN96118724A CN96118724A CN1170578A CN 1170578 A CN1170578 A CN 1170578A CN 96118724 A CN96118724 A CN 96118724A CN 96118724 A CN96118724 A CN 96118724A CN 1170578 A CN1170578 A CN 1170578A
Authority
CN
China
Prior art keywords
capsules
percent
dilong
water
esophageal cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96118724A
Other languages
Chinese (zh)
Inventor
王克为
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Force Medical University
Original Assignee
Fourth Military Medical University FMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourth Military Medical University FMMU filed Critical Fourth Military Medical University FMMU
Priority to CN96118724A priority Critical patent/CN1170578A/en
Publication of CN1170578A publication Critical patent/CN1170578A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Earthworm capsule relates to an active substance-containing active substance product with anticancer function, which is prepared by washing fresh live earthworms with water, homogenating, freezing, thawing, filtering, freeze-drying and encapsulating. According to the determination, the earthworm capsule contains protein, a plurality of amino acids, riboflavin, vitamin C, DNA, RNA, reducing sugar, trace elements and the like. Toxicity tests prove that the Chinese medicinal composition has no toxic or side effect. Through clinical observation, the partial remission rate of 625 cases of late-stage esophageal cancer is 45 percent, the complete remission rate of the advanced-stage esophageal cancer combined with radiotherapy is 33 percent, the curative effect is obvious, and the effective rate of inhibiting lung cancer is 79.2 percent when the advanced-stage esophageal cancer combined with chemotherapy has obvious synergistic effect.

Description

Earthworm capsule
The present invention relates to a kind of pharmaceutical products that contains anti-cancer active matter.
The traditional Chinese medical science thinks that the formation of tumor at first is positive QI-insufficiency, and it is poly-that zang-fu disharmony and cause qi depression to blood stasis, expectorant coagulate poison, and scorchingly hot penting up forms lump, name day " cancer ", " rock ".Though Chinese traditional treatment tumor rule is many, conclude not outer four big rules: method of dissipating heat and detoxifying, hard masses softening and resolving method, activating blood and removing stasis Method and the body resistance strengthening and constitution consolidating method.By blood removing blood stasis with potent drugs soup " the bright experience collection that borders in the south of Zhao " is one of famous anticancer prescription of blood-activating stasis-removing kind.
Form by Hirudo, worm, Pheretima, Semen Pharbitidis, Fructus Liquidambaris, Herba speranskiae tuberculatae, Fructus Polygoni Orientalis, Radix seu Herba Spiranthis Lanceae, Radix Arnebiae (Radix Lithospermi), Tabanus ten flavor Chinese medicines by blood removing blood stasis with potent drugs soup.
The Japan scholar helps the paper that the clear Yan Shi of rattan delivers at him: Chinese prescription research, 1979.2P51 described in: when the research Chinese medicine medicine for preventing, find, Pheretima through decoct, filtration, distilling under reduced pressure and the dry mixture that forms, be 50% to 70% to the suppression ratio of S180 transplanted tumor.
Also propose Pheretima in " clinical efficacy of Chinese medicine medicine for preventing " book of Qian Baiwen work and can be used for treating intracranial tumour (see Qian Baiwen: the clinical efficacy of Chinese medicine medicine for preventing, 113, Shanghai, Shanghai translation issuing company, 1986.1).
Lumbricus is referred to as Pheretima at Chinese medicine, therefore generally not containing poisonous composition, study on its antitumaous effect basis Pheretima as anticancer drug of first choice forefathers, is prerequisite not destroy its active substance, designed the extracting method of working substance, prepared PTS---earthworm capsule.
The objective of the invention is on the basis of forefathers research, go out pure Chinese medicine cancer therapy drug---earthworm capsule with the prepared of uniqueness.This Pheretima capsule contains protein, several amino acids, riboflavin, vitamin C, DNA and RNA, reducing sugar and trace element etc. after measured.Have no side effect through the toxicity test proof.Part remission rate through clinical observation 625 routine late esophagus cancers is 45%; Share with chemotherapeutic, the effective percentage 79.2% that suppresses pulmonary carcinoma has remarkable potentiation; With radiotherapy and usefulness, be 33% to the complete remission rate of the pulmonary carcinoma and the esophageal carcinoma, remarkable potentiation is arranged; With radiotherapy and usefulness, be 33% to the complete remission rate of the pulmonary carcinoma and the esophageal carcinoma, the notable synergistic effect is arranged.
The object of the present invention is achieved like this: earthworm capsule, get raw material Pheretima alive, wash, add water homogenate, freezing 48 hours, melt filtration, lyophilization incapsulates promptly, its detailed process is: new fresh and alive Pheretima, and tap water is cleaned, airing, 3 times of adding distil waters (W/W), with twice of high-speed tissue mashing machine's (800-12000 rev/min) homogenate, each 2 minutes, 20 seconds at interval, homogenate was put in the cryogenic refrigerator (below 20 ℃) freezing 48 hours, through freeze thawing (<36 ℃), centrifugal 3000 rev/mins) 20 minutes, filter by (the quick filter paper of two-layer Xinhua), the cool lyophilizing of filtrate dry (pre-cooling-40 ℃, vacuum 10 2, 33 ℃ of sublimation temperatures, moisture content is lower than 70%) the one-tenth brown powder.
Accompanying drawing is preparation technology's flow chart of the present invention.
Advantage of the present invention is: have promoting blood circulation and removing blood stasis, clearing heat and detoxicating, dispersing swelling and dissipating binds, raising is thin Born of the same parents' immunologic function, inhibition tumor cell generates. Be used for the treatment of especially tumor in digestive tract effect of tumour Significantly, also can be used as the synergist effect of radiotherapy, chemotherapy.
Below in conjunction with embodiment in detail the present invention is described in detail:
Get the dark different lip earthworm 1000g of the back of the body, wash, add water 3000ml, homogenate is twice in high-speed tissue mashing machine, each 2 minutes, be crushed to more than the 10um (diameter) for the first time, be crushed to 3-10um (diameter) for the second time, put then below-20 ℃ and freeze 48hr, room temperature is smashed quick thawing for 30 ℃, and centrifugal 3000 change, and filter and abandon precipitate and suspension larger particles, frozen drying becomes brown powder (pre-cooling-40 ℃, vacuum 10 2, sublimation temperature<33 ℃, moisture is lower than 7%).Divide encapsulated, cobalt 60 1,000,000Behind the rd irradiation-sterilize promptly.

Claims (2)

1.地龙胶囊,其特征在于取原材料活地龙,用水洗净,加水匀浆、冷冻48小时,融化滤过,冷冻干燥,装入胶囊即得。1. Dilong Capsules, which is characterized in that raw material Dilong is taken, washed with water, homogenized with water, frozen for 48 hours, melted and filtered, freeze-dried, and packed into capsules to get final product. 2.根据权利要求1所述的地龙胶囊,其特征在于其制备具体过程为:新鲜活蚯蚓,自来水洗净凉干,加蒸馏水3倍(W/W),用高速组织捣碎机(8000-12000转/分)匀浆两次,每次2分钟,间隔20秒,匀浆液置低温冰箱中(-20℃以下)冷冻48小时,经冻融(<36℃,离心3000转/分)20分钟,过滤,滤液冷冻干燥(预冷-40℃,真空度102,升华温度<33℃水分低于7%)成褐色粉末,分装胶囊即得。2. Dilong Capsules according to claim 1, is characterized in that its concrete preparation process is: fresh and live earthworm, tap water washes and dries, adds distilled water 3 times (W/W), uses high-speed tissue mashing machine ( 8000-12000 rpm) homogenate twice, each time for 2 minutes, with an interval of 20 seconds, the homogenate solution was frozen in a low-temperature refrigerator (below -20°C) for 48 hours, and after freezing and thawing (<36°C, centrifuge at 3000 rpm ) for 20 minutes, filtered, and the filtrate was freeze-dried (pre-cooled at -40°C, vacuum degree 10 2 , sublimation temperature <33°C, water content less than 7%) to brown powder, and then packed into capsules.
CN96118724A 1996-07-17 1996-07-17 Dilong Capsules Pending CN1170578A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96118724A CN1170578A (en) 1996-07-17 1996-07-17 Dilong Capsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96118724A CN1170578A (en) 1996-07-17 1996-07-17 Dilong Capsules

Publications (1)

Publication Number Publication Date
CN1170578A true CN1170578A (en) 1998-01-21

Family

ID=5125291

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96118724A Pending CN1170578A (en) 1996-07-17 1996-07-17 Dilong Capsules

Country Status (1)

Country Link
CN (1) CN1170578A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026683A1 (en) * 2001-09-05 2003-04-03 Xiaoping Zhu Health caring product for enhancing immunity and delaying aging
WO2007017139A1 (en) * 2005-07-29 2007-02-15 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
CN111450120A (en) * 2020-04-26 2020-07-28 安溪县桃源有机茶场有限公司 Earthworm whole powder and preparation method and application thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026683A1 (en) * 2001-09-05 2003-04-03 Xiaoping Zhu Health caring product for enhancing immunity and delaying aging
WO2007017139A1 (en) * 2005-07-29 2007-02-15 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
EA012753B1 (en) * 2005-07-29 2009-12-30 Тима Фаундейшн Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
US8580750B2 (en) 2005-07-29 2013-11-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
US9402849B2 (en) 2005-07-29 2016-08-02 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
CN111450120A (en) * 2020-04-26 2020-07-28 安溪县桃源有机茶场有限公司 Earthworm whole powder and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN118434431A (en) A Chinese medicine composition and its preparation method and application
CN111437378B (en) Traditional Chinese medicine composition and medicine for preventing and treating chronic heart failure and preparation method thereof
CN106110276A (en) A kind of have the complex improving functional gastrointestinal disorder effect
CN111840466A (en) Medical health-care product for enhancing immunity and assisting in treating tumors and preparation method thereof
CN1170578A (en) Dilong Capsules
CN111920903B (en) A kind of pharmaceutical composition for treating radiation oral mucositis and preparation method thereof
CN105597013A (en) Method for preparing traditional Chinese medicine composition for treating post-cholecystectomy syndrome
CN106310023A (en) Drug for treating small cell lung cancer, and preparation method and application thereof
CN105561098A (en) Medicine for treating erosive beriberi
CN100540018C (en) Chinese medicine preparation and application containing fresh deer antler freeze-dried powder
CN108283668A (en) A kind of gastric ulcer composition of American-cockroach-extract-containing and preparation method thereof
CN103169844B (en) Traditional Chinese medicine composition having anti-lung cancer and anti-liver cancer effects
CN101549066A (en) Prescription for treating allergy purpura and method for preparing same
CN102743435B (en) Use of perila seed extract with functions of protecting liver and lowering transaminase
CN113662992A (en) Application of a kind of Pyracantha fruit and medicine for platelet-related diseases
CN116115714B (en) Anti-tumor Chinese medicine composition and its preparation method and application
CN106310069A (en) Chinese herb preparation for treating advanced lung cancer, and preparation method and application thereof
CN105456957A (en) Traditional Chinese medicine composition for treating bromhidrosis
CN114129692B (en) Traditional Chinese medicine composition for treating furunculosis and preparation method and application thereof
CN111544522A (en) Traditional Chinese medicine composition for treating anemia caused by digestive tract tumor and preparation method thereof
KR101752486B1 (en) Composition for Treatment of Pancreatic Cancer and Beauty Expenses Composition Comprising Extract of Pharbitis Semen
CN100455302C (en) Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof
CN101322784B (en) Medicament with stomach-regulating and antidiarrheal efficacy and producing method thereof
CN108743813B (en) Traditional Chinese medicine nano-emulsion for resisting nasopharyngeal carcinoma
CN102166295B (en) A kind of traditional Chinese medicine composition for treating cancer

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication